Insight Express: Your FAST Insight
IQVIA experts explore a new industry hot topic in under two minutes
Feature 1: Overview
Vertical integration is reshaping the healthcare landscape as insurers, PBMs, pharmacies, and providers increasingly operate within the same corporate structures. With most prescriptions processed by a limited number of PBMs, consolidation can introduce new patient access barriers. This episode examines the scale of vertical integration and outlines its implications for prescription access across retail and specialty therapies.
Speaker: Rahel Ehrenberg, Principal, U.S. Market Access Strategy Consulting, IQVIA
Feature 2: Patient Impact
Rising prescription rejection rates aren’t just statistics, they represent real patients facing unexpected barriers at the pharmacy counter. As initial denials increase and a significant share of prescriptions remain unapproved over time, patients must navigate additional administrative steps that can delay or prevent treatment.
Speaker: Kimesha Grant, DNP, MPH, Associate Director, U.S. Thought Leadership & Innovation, IQVIA
Feature 3: Access to Care
Affiliation between PBMs and pharmacies is emerging as a measurable factor in prescription approval outcomes. Prescriptions filled at non-affiliated pharmacies often show higher rejection rates across both specialty and retail products. Using oral oncology and SGLT-2 therapies as examples, this episode explores approval gaps and pharmacy switching patterns.
Speaker: Philippa Johnson, U.S. Market Access Strategy Consulting, IQVIA
Feature 4: Time to approval
Time to approval is a critical and often overlooked dimension of patient access. Differences in PBM and pharmacy affiliation can influence how quickly prescriptions are approved for immunology treatments. This episode examines how vertical integration influences approval rates and timely access to care.
Speaker: Kristen Copley, U.S. Market Access Strategy Consulting, IQVIA
Related solutions
Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance.
Grow your brand, now and through patent expiry
Gain high value access and increase the profitability of your brands